Each of the end-products being developed, are prepared for delivery to contract customers in white-label or in the label of the pharmaceutical companies that forms part of our distributed production line.
Hardolin is co-developing tinctures and soft-gel capsules with two South-American pharmaceutical companies in Uruguay and Paraguay. Additionally, a veterinarian product line is being prepared with an existing market leader in the market.
All consumer products will be made available subject to final permits being issued to the pharmaceutical companies, and are produced by the pharmaceutical companies under their full identity- and reference number.
The products in their final dosage form can also be delivered in white-label to our customers.
All consumer products are produced under medical-GMP by our pharmaceutical partners, and are delivered directly to our whole-sale distributors from their warehouse and under their logistic control so that GMP status is protected all the way to the point of delivery to our distributors.
